{"changes":[{"companyHref":"/c/medcurainc-com","date":"2026-09-25","documentUrl":null,"domain":"medcurainc.com","fact":"latest round","name":"Medcura, Inc.","new":{"amountUsd":38286410,"date":"2025-07-25","lead":null,"type":null},"old":{"amountUsd":38286410,"date":"2025-07-25","lead":null,"type":"seed"},"publisher":"sec-edgar","reason":null,"retrievedAt":"2026-06-05","slug":"medcurainc-com","status":"attributed","url":"https://whoraisedwhat.com/c/medcurainc-com"}],"country":"US","description":"Medcura develops biopolymer hemostatic products that mechanically coat bleeding sites to control surgical, trauma, and consumer bleeding, led by its LifeGel gel for spine surgery. It serves surgeons, trauma settings, and payers seeking lower-cost hemostasis. Its edge is a flowable gel that resists swelling, with FDA Breakthrough Device designation.","domain":"medcurainc.com","employees":null,"founded":null,"fundingTotalQuarantined":false,"githubOrg":null,"githubStars":null,"industry":"biotechnology","investors":[],"lat":38.962954,"lng":-76.934958,"location":"Riverdale, Maryland","name":"Medcura, Inc.","rounds":[{"amountQuarantined":false,"amountUsd":38286410,"currency":"USD","date":"2025-07-25","investors":[],"leadInvestor":null,"source":{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-06-05","status":"attributed","url":null},"status":"attributed","type":null,"url":null}],"slug":"medcurainc-com","sources":[{"fact":"round","publisher":"sec-edgar","retrievedAt":"2026-06-05","status":"attributed","url":null},{"fact":"existence","publisher":"medcurainc.com","retrievedAt":"2026-06-05","status":"self-reported","url":"https://medcurainc.com"},{"fact":"description","publisher":"medcurainc.com","retrievedAt":"2026-06-05","status":"self-reported","url":"https://medcurainc.com"}],"stage":null,"techStack":["@sentry/browser","cloudflare","google font api","google hosted libraries","hsts","http/3","jquery 3.5.1","wistia"],"totalRaisedUsd":38286410,"updatedAt":"2026-06-05"}